Tab. 2.
Description of studies
| Study | OA grade | Mean FUP | Control | Outcome measures | Preparation | Complications |
|---|---|---|---|---|---|---|
| Di Sante et al. 2016(17) | KL: II i III | 16 weeks | HA | VAS, WOMAC | 8 mls blood, 4 mls PRP 3 weekly injections | None |
| Dallari et al. 2016(18) | KL: I–IV | 12 months | HA | VAS, WOMAC, HHS | 150 mls blood, 4 × 5 mls PRP 3 weekly injections | None |
| Battaglia et al. 2013(19) | KL: II, III i IV | 12 months | HA | VAS, HHS | 150 mls blood, 4 × 5 mls PRP 3 weekly injections | 1 superficial haematoma |